Trading Statement Aspen Pharmacare Holdings Limited (Incorporated in the Republic of South Africa) (Registration number 1985/002935/06) Share code: APN & ISIN: ZAE000066692 ("Aspen") Trading statement Aspen shareholders are hereby advised that diluted normalised headline earnings per share (“DNHEPS”) from continuing operations, headline earnings per share and earnings per share for the 12 months ended 30 June 2013 are expected to exceed those reported in the comparative period, ended 30 June 2012, within the following ranges: Measure Range Notes DNHEPS from continuing operations 26% to 33% 1 Headline earnings per share 16% to 23% 2 Earnings per share 16% to 23% 3 Notes: 1. DNHEPS from continuing operations comprises diluted headline earnings per share adjusted for specific non-trading items. DNHEPS is the primary measure used by management to assess Aspen’s underlying financial performance. 2. The growth in headline earnings per share has been diluted by the effect of an increase in the weighted average number of ordinary shares in issue as a consequence of the conversion of 17.6 million preference shares into an equivalent number of ordinary shares on 28 June 2012. 3. The growth in earnings per share has been diluted as a result of capital profits on the disposal of discontinued businesses and products in the prior year and the effect of an increase in the weighted average number of ordinary shares in issue as a consequence of the conversion of 17.6 million preference shares into an equivalent number of ordinary shares on 28 June 2012. The financial results on which this trading announcement is based have not been reviewed or reported on by Aspen`s external auditors. Aspen`s audited results for the 12 months ended 30 June 2013 are scheduled to be published on SENS on 11 September 2013. Durban 30 August 2013 Sponsor: Investec Bank Limited Date: 30/08/2013 01:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.